顯示第 49 至 64 項結果,共 450 項
-
Anti-CD40L [hu5c8 (Ruplizumab)] (Ab00447-2.0-BT)
-
Anti-CD40L [hu5c8 (Ruplizumab)] (Ab00447-2.0)
-
Anti-CD41 [7E3 (Abciximab)] (Ab00282-2.0-BT)
-
Anti-CD41 [7E3 (Abciximab)] (Ab00282-2.0)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-1.1-BT)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-1.1)
-
Anti-CMV [EIV-15] (Ab02246-1.1-BT)
-
Anti-CMV [EIV-15] (Ab02246-1.1)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-1.6-BT)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-1.6)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-1.7-BT)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-1.7)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-21.0-BT)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-21.0)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-3.0-BT)
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] (Ab01691-3.0)
